Aspira Womens Health Inc (AWH)
2.95
-0.13
(-4.22%)
USD |
NASDAQ |
May 10, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Aspira Womens Health Enterprise Value: 37.69M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 37.69M |
| May 08, 2024 | 36.45M |
| May 07, 2024 | 36.08M |
| May 06, 2024 | 39.29M |
| May 03, 2024 | 39.29M |
| May 02, 2024 | 39.33M |
| May 01, 2024 | 39.42M |
| April 30, 2024 | 39.42M |
| April 29, 2024 | 40.77M |
| April 26, 2024 | 40.73M |
| April 25, 2024 | 40.16M |
| April 24, 2024 | 41.64M |
| April 23, 2024 | 41.52M |
| April 22, 2024 | 42.87M |
| April 19, 2024 | 42.75M |
| April 18, 2024 | 43.24M |
| April 17, 2024 | 42.75M |
| April 16, 2024 | 42.26M |
| April 15, 2024 | 41.52M |
| April 12, 2024 | 42.26M |
| April 11, 2024 | 39.42M |
| April 10, 2024 | 39.42M |
| April 09, 2024 | 37.94M |
| April 08, 2024 | 34.48M |
| April 05, 2024 | 32.26M |
| Date | Value |
|---|---|
| April 04, 2024 | 33.00M |
| April 03, 2024 | 34.23M |
| April 02, 2024 | 33.43M |
| April 01, 2024 | 36.58M |
| March 28, 2024 | 37.94M |
| March 27, 2024 | 42.01M |
| March 26, 2024 | 42.87M |
| March 25, 2024 | 43.61M |
| March 22, 2024 | 44.72M |
| March 21, 2024 | 44.23M |
| March 20, 2024 | 42.56M |
| March 19, 2024 | 43.49M |
| March 18, 2024 | 44.72M |
| March 15, 2024 | 37.99M |
| March 14, 2024 | 38.84M |
| March 13, 2024 | 38.74M |
| March 12, 2024 | 38.63M |
| March 11, 2024 | 39.37M |
| March 08, 2024 | 38.63M |
| March 07, 2024 | 39.48M |
| March 06, 2024 | 40.33M |
| March 05, 2024 | 40.97M |
| March 04, 2024 | 41.50M |
| March 01, 2024 | 42.20M |
| February 29, 2024 | 41.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.97M
Minimum
Jun 06 2023
1.007B
Maximum
Feb 11 2021
186.40M
Average
67.72M
Median
Jan 03 2020
Enterprise Value Benchmarks
| Bruker Corp | 12.14B |
| Azenta Inc | 1.885B |
| Harvard Bioscience Inc | 185.91M |
| Bionano Genomics Inc | 33.60M |
| Akoya Biosciences Inc | 211.79M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.089M |
| Revenue (Quarterly) | 2.13M |
| Total Expenses (Quarterly) | 6.265M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | 57.23% |
| Profit Margin (Quarterly) | -145.0% |
| Earnings Yield | -60.68% |
| Normalized Earnings Yield | -66.48 |